Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial efflux pumps are membrane-bound transport proteins that actively expel a wide range of substrates—including antibiotics, toxins, detergents, dyes, and metabolic waste—from the interior of bacterial cells to the external environment. This process, known as active efflux, is a crucial mechanism by which bacteria develop resistance to multiple antibiotics. They are classified into several superfamilies including ABC, MFS, RND, SMR, MATE and PACE. Efflux-mediated drug resistance poses significant challenges in treating bacterial infections. Inhibiting these pumps has emerged as a promising strategy for restoring antibiotic efficacy.
Active transport of substrates across bacterial membranes, reducing intracellular concentration of antimicrobials. Efflux pump inhibitors aim to block this transport, restoring antibiotic efficacy.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial Efflux Pump (Efflux Pump).